Carter Bruce L A's Form 4 filing
Enanta Pharmaceuticals Inc (ENTA) · filed Mar 22, 2022
- Accession no.
- 0001062993-22-008344
- Filed
- Mar 22, 2022
- Trade date
- Mar 21, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $407.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carter Bruce L ACIK 0001225503 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2022 | Common Stock | MOption exerciseAcquired | +6,000 | $25.58 | +$153,480 | 6,000 | Direct | |
| Mar 21, 2022 | Common Stock | SSaleDisposed | −2,676 | $66.70 | −$178,489.2 | 3,324 | Direct | |
| Mar 21, 2022 | Common Stock | SSaleDisposed | −307 | $67.23 | −$20,639.61 | 3,017 | Direct | |
| Mar 21, 2022 | Common Stock | SSaleDisposed | −2,210 | $68.66 | −$151,738.6 | 807 | Direct | |
| Mar 21, 2022 | Common Stock | SSaleDisposed | −807 | $69.52 | −$56,102.64 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2022 | Common Stock | MOption exerciseDisposed | −6,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.